6525--Intent to Sole Source: TheraSphere Y-90 Glass Microspheres 36C24726Q0265
Summary
AI-generated · Feb 06, 2026Provide TheraSphere Y-90 Glass Microspheres for targeted radiation therapy to treat liver cancer at the Ralph H. Johnson VA Medical Center in Charleston, SC. The treatment delivers Yttrium-90 beta radiation via the hepatic artery to kill cancer cells while sparing healthy tissue.
A sole-source, firm-fixed-price contract is planned with Boston Scientific Corporation under FAR 6.302-1. The base period covers 24 months, with two additional 12-month option periods. This notice is not a request for competitive quotes or proposals, and no award will be made based on responses to this notice. A written justification for the sole-source action will be posted within 14 days after contract award if applicable. Interested, responsible sources may submit capability statements for consideration by the closing date; the Government will determine, at its discretion, whether to pursue a competitive procurement.
INTENT TO SOLE SOURCE GENERAL INFORMATION Contracting Office Address Network Contracting Officer (NCO) 7 ATTN: LaTerrica Sewell Department of Veterans Affairs 501 Greene Street Hatcher Building Suite 2 Augusta, GA 30901 This notice follows the Federal Acquisition Regulation Deviations outlined in the Federal Acquisition Regulation Overhaul as required by Executive Order (E.O.) 14275, Restoring Common Sense to Federal Procurement, signed April 15, 2025. Intent to Sole Source: The Government plans to issue a sole-source, firm-fixed-price contract in accordance with Federal Acquisition Regulations (FAR) 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements , with Boston Scientific Corporation to provide TheraSphere Y-90 Glass Microspheres. This requirement is for ongoing services of providing TheraSphere Y-90 Glass Microspheres at the Ralph H. Johnson Veteran Affairs Medical Center located in Charleston, SC. The services at the facility are necessary to provide targeted radiation therapy using microscopic glass beads containing radioactive Yttrium-90 (Y-90) to treat liver cancers, delivering high-dose beta radiation directly to tumors via the hepatic artery to kill cancer cells while sparing healthy tissue. Services will be from 05/01/2025 through 04/30/2027 with two (2) twelve (12) month option periods. The designated source is Boston Scientific at 300 Boston Scientific Way, Marlborough, MA, 01752. In accordance with FAR Part 6, contracts awarded using this authority must be supported by a written justification, and approval will be posted within fourteen (14) days after contract award if the dollar amount meets the threshold. The Government will review all capability statements received by the closing date of this synopsis. The decision not to compete based on responses is solely at the Government's discretion. The information received will be used only to determine whether to pursue a competitive procurement. The applicable North American Industry Classification System (NAICS) code for this work is 325412 - Pharmaceutical Preparation Manufacturing, with a size standard of 1,300 Employees. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS or PROPOSALS. No contract award will be made based on quotations or proposals received in response to this notice. No solicitation document exists, and no telephone or email inquiries will be accepted. Any responsible source that believes it can meet the requirement may submit a capability statement to LaTerrica.Sewell@va.gov no later than February 20, 2026, at 10:00 AM Eastern Time (ET). Please ensure that notice # is cited on all submitted documents to ensure they are properly processed. Disclaimer and Important Notes: Do not include proprietary, classified, confidential, or sensitive information in responses to this notice. This notice does not obligate the Government to award a contract. The Government will not pay for information provided in response to this notice. The Government reserves the right to use the information respondents provide for market research purposes. The Government is under no obligation to acknowledge receipt of or respond to any information submitted.
From Special Notice posted on Feb 05, 2026Notice history
1Details
Award Information
Contacts
Contracting Officer
Phone